Home › Atherosclerosis › Connecticut › Waterbury
Atherosclerosis clinical trials in Waterbury, CT
3 studies for Atherosclerosis are looking for participants at sites in and around Waterbury (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Chase Medical Research, LLC, Waterbury
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Nephrology and Hypertension Associates PC, Middlebury · 4 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Waterbury
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Arlington, VA8 studies
- Orlando, FL8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Minneapolis, MN6 studies
Other studies in Waterbury
- Non-Small Cell Lung Cancer6 studies
- Lung Cancer6 studies
- Obesity6 studies
- Overweight6 studies
- Breast Cancer6 studies
- Cardiovascular Disease4 studies
- Esophageal Adenocarcinoma3 studies
- High Blood Pressure3 studies
- Multiple Myeloma3 studies
- Heart Attack3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.